InvestSMART

Biome Australia Limited (ASX:BIO)

ALERT: Price-sensitive ASX Announcement for BIO
Current share price for BIO : $0.400 0.145 (56.86%)+
Release
27 Jul 2026 9:34AM
Price at Release
$0.255
Full Release
download
Summary
Biome Australia Limited's report outlines their strategic expansion into international markets following a successful model in Australia with practitioner-only, clinically backed probiotic products. The company reported a significant revenue increase in FY26, driven by operations in Canada, the UK, Ireland, and New Zealand. They focus on maintaining premium pricing and protecting brand integrity while enhancing supply chain efficiency through onshore manufacturing. New initiatives, such as the B2B2C portal, aim to streamline practitioner access. They also established a supply chain hub in Northern Ireland to facilitate EU distribution. Biome Australia, a certified B Corporation, is committed to social and environmental responsibilities while showing improved operating leverage and gross margins.
Key Points
  • Practitioner-only model with clinically proven probiotics.
  • Expansion from Australia to international markets.
  • Significant revenue growth in FY26 with a focus on profitability.
  • Targeting four international markets: Canada, UK, Ireland, and New Zealand.
  • Focus on maintaining premium pricing and brand equity.
  • Onshore manufacturing initiated to enhance supply chain efficiency.
  • New initiatives like B2B2C portal for direct wholesale to practitioners.
  • Establishing EU supply chain hub in Northern Ireland.
  • Certified B Corporation with a commitment to social and environmental responsibility.
  • Financial performance showing operating leverage and margin improvement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.